Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.63 -0.18 (-3.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vanda Pharmaceuticals (VNDA) Other Accumulated Expenses (2011 - 2026)

Updated

Vanda Pharmaceuticals' Other Accumulated Expenses was $94.03 million in Q2 2026, up 46.1% from $64.37 million a year earlier and up 25.4% from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Vanda Pharmaceuticals came in at $76.87 million, up 26.2% from FY2024.

  • Other Accumulated Expenses has now increased for eight consecutive years, with a five-year compound annual growth rate of 17.4% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $60.9 million in FY2024 (+23.7%), $49.24 million in FY2023 (+7.3%), $45.89 million in FY2022 (+14.8%) and $39.98 million in FY2021 (+16.1%).
  • The Q2 2026 figure marks the highest quarterly Other Accumulated Expenses in data going back to Q4 2011.
  • Compared with a year earlier, Other Accumulated Expenses has increased for seven straight quarters, with growth averaging 23.1% over the last eight quarters.
  • The best year-over-year quarter for Other Accumulated Expenses over five years was Q1 2023 (growth of 49.2%); the worst was Q1 2024 (a decline of 5.3%).
  • Per Business Quant data, VNDA's Other Accumulated Expenses in the three quarters before Q2 2026 was $74.96 million (Q1 2026), $76.87 million (Q4 2025) and $70.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Vanda Pharmaceuticals 279.91 Mn -650.03 Mn 46.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.03 Mn
Mar 31, 2026 74.96 Mn
Dec 31, 2025 76.87 Mn
Sep 30, 2025 70.25 Mn
Jun 30, 2025 64.37 Mn
Mar 31, 2025 58.64 Mn
Dec 31, 2024 60.90 Mn
Sep 30, 2024 49.79 Mn
Jun 30, 2024 54.19 Mn
Mar 31, 2024 55.57 Mn
Dec 31, 2023 49.24 Mn
Sep 30, 2023 52.24 Mn
Jun 30, 2023 55.47 Mn
Mar 31, 2023 58.70 Mn
Dec 31, 2022 45.89 Mn
Sep 30, 2022 42.50 Mn
Jun 30, 2022 38.16 Mn
Mar 31, 2022 39.35 Mn
Dec 31, 2021 39.98 Mn
Sep 30, 2021 40.18 Mn
API Access

Vanda Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VNDA&period=max&api_key=YOUR_API_KEY